02591.HK
Guangzhou Innogen Pharmaceutl Grp Co Ltd
HKSE · Healthcare · Biotechnology · CN
HKD 3.85
+0.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 12.00x
- P/S forward
- 18.88x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.55x
- Price / sales
- 9.65x
- Price / cash flow
- -4.23x
Enterprise value
- Enterprise value
- HKD 683.2M
- EV / sales
- 3.87x
- EV / EBITDA
- -1.83x
- EV / EBIT
- -1.76x
- Market cap
- HKD 1.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026